CClinicalTrials.gg
RecruitingNCT05557305Updated May 7, 2024

Changes in Motor and Cognitive Function on Unilateral Spastic Cerebral Palsy, Associated With Videogame Therapy

An interventional study of Videogame therapy and Conventional therapy in Cerebral Palsy, Spastic and Hemiplegia, Spastic, sponsored by Universidad Nacional Autonoma de Mexico. Recruiting at 1 site in Mexico. Open to participants aged 5 Years to 18 Years. Per ClinicalTrials.gov, last updated 2024-05-07.

Sponsored by Universidad Nacional Autonoma de Mexico · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by May 2025, 1 year 5 months ago, but the record still lists the study as recruiting.
  • Started Dec 2022; still recruiting 3 years 9 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
84
Allocation
Randomized
Ages
5 Years to 18 Years
Sex
All
01

Study summary

The use of interactive applications associated with position and movement sensors has begun to spread as an option for the reinforcement of physical rehabilitation therapies in patients with congenital or acquired motor disorders as a result of some neurological damage, due to its portability and the relative autonomy granted to the patient. However, the results of its effectiveness and impact continue to be scarce compared to the traditional therapy used for rehabilitation. The aim of this study is to explore possible benefits associated with occupational therapy with video games in patients with unilateral spastic cerebral palsy, comparing them with conventional therapy.

A randomized pilot study will be carried out, with a control group. The intervention will consist of the application of a virtual rehabilitation program for the experimental group while the control group will receive only conventional therapy. Before and after the said intervention, standardized tests will be applied to evaluate both motor function and the cognitive performance of the participants.

Read the detailed description

This intervention protocol aims to validate five interactive applications for neurorehabilitation, as an effective therapeutic complement for the rehabilitation of children with unilateral cerebral palsy, compared to conventional rehabilitation.

The intervention contemplates first a phase of application of standardized tests in the Cognitive enablement lab of the National Institute of pediatrics (INP) in Mexico City, to determine, among other things, if the patient meets the established inclusion criteria. Patients who meet these criteria will be randomly assigned to the control or experimental group.

In the same INP, standardized tests will be applied to record their motor and cognitive capacity at the beginning of the protocol. Patients in the experimental group will receive two 50-minute video game rehabilitation sessions per week, for 10 weeks, under the supervision of trained personnel from the Laboratory of Applications for Neurorehabilitation (LANR). Control group patients will receive 10 weeks of occupational therapy, as prescribed by their treating physician.

All standardized tests will be applied again to the participants of both groups after the 10 weeks of intervention, and again six months later, to measure the persistence of the changes.

In the case of the experimental group, five interactive applications will be tested, each with a different sensor and virtual environment, as well as its own therapeutic objective, these applications are part of the National Autonomous University of Mexico (UNAM) virtual rehabilitation platform.

02

Conditions studied

  • Cerebral Palsy, Spastic
  • Hemiplegia, Spastic

Keywords

  • virtual rehabilitation
  • video games
  • motor function
  • spastic hemiparesis
  • cerebral palsy
  • unilateral spastic cerebral palsy
03

In context

Muscle Spasticity

704 studies on the registry are indexed under Muscle Spasticity; 149 are open to participants now.

This study's planned enrollment of 84 is above the median of 36 across 525 interventional studies indexed under Muscle Spasticity.

Browse Muscle Spasticity studies →

Lead sponsor

Universidad Nacional Autonoma de Mexico is the lead sponsor of 28 studies on the registry; 9 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
5 Years to 18 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Outpatients
  • Both genders
  • Reside in Mexico City and the metropolitan area
  • Between 5 and 18 years old
  • With upper extremity hemiparesis caused by Unilateral Spastic Cerebral Palsy (USCP) on their dominant side or not
  • Who are at levels I-III of the Manual Ability Classification System for Children with Cerebral Palsy (MACS)
  • Score equal to or greater than 20 on the Fugl-Meyer upper extremity scale.

Exclusion criteria

Exclusion Criteria:

  • Patients with joint instability (shoulder, elbow, or wrist)
  • With severe concomitant medical problems such as congestive heart failure or seizures that prevent adequate attention to the task.
  • Severe aphasia
  • Hemineglect
  • Visual disturbances that are not corrected with glasses
  • Uncompensated hearing impairment
  • Inability to understand instructions (Token Test \< 17)
  • Patients receiving concurrent therapies.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
84 participants (estimated)

Study arms

  • Experimental
    Videogame therapy

    The participants of the experimental group will only undergo video game therapy and will be called twice a week to perform supervised video game rehabilitation therapy, for a period of 45-50 minutes per session, for 10 weeks

    Device: Videogame therapy

  • Active comparator
    Conventional therapy

    The participants in the control group will undergo the conventional therapy prescribed by their treating physician, at the INP they are prescribed occupational therapy, which is usually focused on game activities with balls, dice, cubes, tying ropes, etc., twice a week for 10 weeks.

    Other: Conventional therapy

Interventions

  • DeviceVideogame therapy

    There will be 5 video game-type applications for virtual therapy, each with a specific therapeutic objective, which will be administered by trained personnel, depending on the characteristics of each patient.

    Also known as: Virtual rehabilitation

  • OtherConventional therapy

    Occupational therapy with different play materials

    Also known as: Occupational therapy

06

What researchers measure

Primary outcomes

  1. Change in the Fugl-Meyer Assesment for upper extremity (FMUE)

    Level of motor deficit, evaluated using the Fugl-Meyer Assessment scale for the upper limb (0-66), with 66 meaning no defficit.

    Time frame: Baseline, 10 Weeks, 6 months

  2. Change in the Quality of Upper Extremity Skills Test (QUEST)

    Upper limb motor skill level, obtained through the Quality of Upper Extremity Skills Test (less than 0 to 100), with 100 being the best quality of movement.

    Time frame: Baseline, 10 Weeks, 6 months

Secondary outcomes

  1. Change in the PedsQl pediatric quality of life questionnaire

    Level of independence in performing activities of daily living (ADLs), assessed using the PedsQl pediatric quality of life questionnaire (0-132) with 0 as the highest score.

    Time frame: Baseline, 10 Weeks, 6 months

  2. Change in the digital version of the Trail Making Test (TMT-A)

    Changes in cognitive function in terms of speed of executive functions and attention, measured by a digitized version of the Trail Making Test A.

    Time frame: Baseline, 10 Weeks, 6 months

  3. Change in the digital version of the Corsi cube test.

    Changes in working memory measured by the Corsi Cubes test.

    Time frame: Baseline, 10 Weeks, 6 months

  4. Change in the digital version of the Perception of differences test (FACES)

    Changes in visual perception, using the perception of differences test

    Time frame: Baseline, 10 Weeks, 6 months

  5. Change in the Digital implementation of the Go-NoGo paradigm.

    Changes in inhibition and flexibility functions, measured using a digital implementation of the Go-NoGo paradigm

    Time frame: Baseline, 10 Weeks, 6 months

07

Study locations

1 of 1 sites recruiting
  • Instituto Nacional de Pediatría
    Mexico City, Coyoacán, CDMX 04530, Mexico
    Recruiting
08

References and documents

Publications

  • Escalante-Gonzalbo AM, Ramirez-Graullera YS, Pasantes H, Aguilar-Chale JJ, Sanchez-Castillo GI, Escutia-Macedo XA, Briseno-Soriano TM, Franco-Castro P, Estrada-Rosales AL, Vazquez-Abundes SE, Andrade-Morales D, Hernandez-Franco J, Palafox L. Safety, Feasibility, and Acceptability of a New Virtual Rehabilitation Platform: A Supervised Pilot Study. Rehabil Process Outcome. 2021 Aug 7;10:11795727211033279. doi: 10.1177/11795727211033279. eCollection 2021. PubMed 34987304 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 7, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05557305
Lead sponsor
Universidad Nacional Autonoma de Mexico
Collaborators
National Institute of Pediatrics, Mexico
Responsible party
Ana María Escalante Gonzalbo (Head of the Laboratory of neurorehabilitation (LANR) IFC, UNAM, Universidad Nacional Autonoma de Mexico) — Principal investigator
First posted
Sep 28, 2022
Start date
Dec 22, 2022
Primary completion
May 2025 (estimated)
Completion
Dec 2025 (estimated)
Last update
May 7, 2024

Study contacts

Ana María Escalante-Gonzalbo, MCompSci
Contact
aescalan@ifc.unam.mx
525556225730
Eduardo Espinosa-Garamendi, PhD
Contact
eduardogaramendi@hotmail.com
525635280056
Ana María Escalante-Gonzalbo, MCompSci
principal investigator · National University of Mexico

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion